跳至主要内容
临床试验/NCT04523311
NCT04523311已完成不适用

An Evaluation of Brief Online Hypnosis for Migraine and Tension-type Headaches

Canterbury Christ Church University1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2020年10月27日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
35
试验地点
1
主要终点
Change from baseline at 7-8 weeks in mean headache rating averaged over 2 weeks of headache diary entries.

研究概览

简要总结

This study aims to conduct an initial evaluation of whether a single, online, group-based session of hypnosis followed by self-hypnosis can decrease symptoms of migraine and tension-type headaches as well as improve quality of life and perceived self-efficacy over the condition.

详细描述

This study is a pilot randomised controlled trial (RCT) comparing a single, online, group-based session of hypnosis followed by self-hypnosis for people with migraines or tension-type headaches with a wait-list control. A battery of self-report measures and a 2-week headache diary will be administered online at baseline (weeks 0 and 1), post-intervention (weeks 7 and 8) and at follow-up (weeks 11 and 12).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Self-reported diagnosis of migraine or tension-type headaches from a General Practitioner (i.e. family physician) and/or specialist physician.
  • •Score above the cut-off for either migraine or tension-type headache on the Headache Screening Questionnaire.
  • •Have experienced at least one headache every two weeks over the last 3 months.
  • •Otherwise healthy physically and mentally.
  • •Able to understand written and spoken English.
  • •Have the IT equipment necessary to access Zoom videoconferencing and the Qualtrics survey system.

排除标准

  • •Substantial medical or psychiatric co-morbidities including diagnoses of epilepsy, psychosis or personality disorder, and/or taking psychiatric medication.
  • •A diagnosis of medication overuse headache.

研究组 & 干预措施

Hypnosis + usual care

Experimental

An online, group-based, single session hypnosis workshop followed by 2 weeks of self hypnosis. Participants will continue with whatever usual care they receive/undertake.

干预措施: Hypnosis. (Behavioral)

Hypnosis + usual care

Experimental

An online, group-based, single session hypnosis workshop followed by 2 weeks of self hypnosis. Participants will continue with whatever usual care they receive/undertake.

干预措施: Usual care (Other)

Waitlist control + usual care

Other

The control group will receive no intervention beyond whatever usual care they receive/undertake. After the study is complete, they will be offered the option of participating in the hypnosis intervention.

干预措施: Usual care (Other)

结局指标

主要结局

Change from baseline at 7-8 weeks in mean headache rating averaged over 2 weeks of headache diary entries.

时间窗: Post intervention (weeks 7-8)

At baseline (weeks 0-1) and post-intervention (weeks 7-8), participants will complete a headache diary for two weeks. The diary comprises hourly ratings of headache intensity (during waking hours) on a 0-5 scale, with higher scores indicating greater migraine/tension-type headache symptom burden. The mean rating over two weeks is used.

次要结局

  • Change from baseline at 11-12 weeks in mean headache duration over 2 weeks of headache diary entries.(Follow-up (weeks 11-12))
  • Change from baseline at week 7 on the Warwick-Edinburgh Mental Wellbeing (WEMWBS) Scale(Post intervention (week 7))
  • Change from baseline at 11-12 weeks in headache frequency over 2 weeks of headache diary entries.(Follow-up (weeks 11-12))
  • Change from baseline at week 7 on the Depression, Anxiety and Stress Scales - 21 item version (DASS-21)(Post intervention (week 7))
  • Change from baseline at week 11 on the Warwick-Edinburgh Mental Wellbeing (WEMWBS) Scale(Follow-up (week 11))
  • Change from baseline at week 7 on the Headache-Specific Locus of Control Scale (HSLC).(Post intervention (week 7))
  • Change from baseline at week 7 on the Headache Management Self-efficacy Scale (HMSE).(Post intervention (week 7))
  • Change from baseline at 11-12 weeks in mean headache rating averaged over 2 weeks of headache diary entries.(Follow-up (weeks 11-12))
  • Change from baseline at 7-8 weeks in headache frequency over 2 weeks of headache diary entries.(Post intervention (weeks 7-8))
  • Change from baseline at 7-8 weeks in mean headache duration over 2 weeks of headache diary entries.(Post intervention (weeks 7-8))
  • Change from baseline at week 11 on the Depression, Anxiety and Stress Scales - 21 item version (DASS-21)(Follow-up (week 11))
  • Change from baseline at week 11 on the Headache-Specific Locus of Control Scale (HSLC).(Follow-up (week 11))
  • Change from baseline at 11-12 weeks in headache related medication consumption over a two week period.(Follow-up (weeks 11-12))
  • Change from baseline at week 11 on the Headache Management Self-efficacy Scale (HMSE).(Follow-up (week 11))
  • Change from baseline at 7-8 weeks in headache related medication consumption over a two week period.(Post intervention (weeks 7-8))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验